Kanawha Capital Management LLC increased its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 185,353 shares of the company’s stock after buying an additional 251 shares during the quarter. Procter & Gamble comprises about 2.2% of Kanawha Capital Management LLC’s holdings, making the stock its 9th largest position. Kanawha Capital Management LLC’s holdings in Procter & Gamble were worth $29,530,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Kingstone Capital Partners Texas LLC boosted its holdings in Procter & Gamble by 655,209.0% in the 2nd quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock valued at $11,832,680,000 after purchasing an additional 76,017,350 shares in the last quarter. Northern Trust Corp boosted its holdings in Procter & Gamble by 0.8% in the 1st quarter. Northern Trust Corp now owns 29,644,000 shares of the company’s stock valued at $5,051,930,000 after purchasing an additional 248,792 shares in the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Procter & Gamble by 13.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company’s stock valued at $3,660,737,000 after purchasing an additional 2,466,308 shares in the last quarter. Goldman Sachs Group Inc. boosted its holdings in Procter & Gamble by 3.5% in the 1st quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company’s stock valued at $2,966,252,000 after purchasing an additional 583,629 shares in the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Procter & Gamble by 6.3% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company’s stock valued at $2,947,146,000 after purchasing an additional 1,018,865 shares in the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Procter & Gamble Trading Up 1.3%
Shares of Procter & Gamble stock opened at $151.53 on Friday. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. Procter & Gamble Company has a 1 year low of $146.96 and a 1 year high of $180.43. The company has a market capitalization of $354.66 billion, a P/E ratio of 23.28, a P/E/G ratio of 3.97 and a beta of 0.36. The business has a 50 day moving average price of $154.92 and a 200 day moving average price of $158.84.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, November 17th. Investors of record on Friday, October 24th will be given a dividend of $1.0568 per share. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date is Friday, October 24th. Procter & Gamble’s payout ratio is currently 64.82%.
Analyst Upgrades and Downgrades
A number of brokerages have weighed in on PG. Wells Fargo & Company lowered their price objective on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating on the stock in a report on Thursday, September 25th. Berenberg Bank lifted their price objective on Procter & Gamble from $152.00 to $154.00 and gave the company a “hold” rating in a report on Wednesday, September 17th. JPMorgan Chase & Co. decreased their price target on Procter & Gamble from $170.00 to $163.00 and set a “neutral” rating on the stock in a research note on Friday, October 10th. Weiss Ratings reissued a “hold (c+)” rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. Finally, Evercore ISI reissued an “in-line” rating and set a $170.00 price target (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $172.21.
Get Our Latest Stock Report on PG
Insider Activity
In other Procter & Gamble news, CEO Jon R. Moeller sold 40,119 shares of the business’s stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $6,309,515.13. Following the completion of the transaction, the chief executive officer directly owned 319,375 shares in the company, valued at approximately $50,228,106.25. The trade was a 11.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Shailesh Jejurikar sold 13,039 shares of the business’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares of the company’s stock, valued at $4,409,221.72. This trade represents a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is owned by corporate insiders.
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- This AI Chip Giant Could Be the Market’s Next Big Winner
- What Are Earnings Reports?
- Broadcom Inks OpenAI Deal: Why It’s A Huge Win for AVGO Stock
- How to Invest in Biotech Stocks
- Institutions Are Fueling CrowdStrike’s Next Leg Higher
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.